Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery
Clinical trial NCT02573610 · COMPLETED
Trial details
- NCT number
- NCT02573610
- Sponsor
- Santen Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-21
- Primary completion
- 2017-03-31
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.